Innovation Pharmaceuticals Inc.
IPIX · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | -$0 | $0 | $0 |
| % Growth | 100% | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | $0 |
| % Margin | – | 1,650% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | 9,650% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | 11,350% | – | – |
| EPS Diluted | -0.002 | -0.001 | -0.002 | -0.001 |
| % Growth | -30.8% | 13.3% | -114.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |